|
Originally published In Press as doi:10.1074/jbc.M205424200 on October 24, 2002
J. Biol. Chem., Vol. 278, Issue 1, 27-36, January 3, 2003
PAX3-FKHR Transformation Increases 26 S
Proteasome-dependent Degradation of p27Kip1, a
Potential Role for Elevated Skp2 Expression*
Lei
Zhang and
Chiayeng
Wang
From the Center for Molecular Biology of Oral Diseases, University
of Illinois at Chicago, Chicago, Illinois 60612
PAX3-FKHR is an oncogenic form of the
developmental regulator Pax3 transcription factor. PAX3-FKHR results
from a t(2,13) chromosomal translocation, a unique genetic
marker of alveolar rhabdomyosarcoma. In this study, we showed that
ectopic expression of PAX3-FKHR, but not Pax3, in fibroblasts altered
cell cycle control and accelerated G0/G1
to S cell cycle transition. PAX3-FKHR-expressing cells had reduced
expression of p27Kip1 protein, a key cell cycle regulator.
The reduction in p27Kip1 levels by PAX3-FKHR resulted from
destabilization of p27Kip1 as shown by cycloheximide
treatment and in vivo pulse-chase labeling experiments. The
reduced p27Kip1 protein level in PAX3-FKHR-expressing cells
was restored to the level of control cells by treatment with chemical
inhibitors that specifically blocked 26 S proteasome activity. Along
with the reduction in p27Kip1 protein, PAX3-FKHR-expressing
cells exhibited elevated expression of F-box Skp2 protein, a
substrate-specific component of SCF (Skp1-Cullin-F box protein) ligase
involved in the cell cycle-dependent control of
p27Kip1 ubiquitination and 26 S proteasome dependent
degradation. Finally, we showed that ectopic expression of
p27Kip1 in PAX3-FKHR-expressing cells significantly reduced
the proliferation and colony-forming potential of these cells,
implicating that down-regulation of p27Kip1 protein played
an active role in the PAX3-FKHR-directed cell transformation.
*
This work was supported by National Institutes of Health
Grant CA-74907 (to C. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: CMBOD, University of
Illinois at Chicago, 801South Paulina St., Chicago, IL 60612. Tel.:
312-996-4530; Fax: 312-413-1604; E-mail:
chiayeng@tigger.cc.uic.edu.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Nishijo, Q.-R. Chen, L. Zhang, A. T. McCleish, A. Rodriguez, M. J. Cho, S. I. Prajapati, J. A.L. Gelfond, G. B. Chisholm, J. E. Michalek, et al.
Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma
Cancer Res.,
April 1, 2009;
69(7):
2902 - 2911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sakai, H. Sakaue, T. Nakamura, M. Okada, Y. Matsuki, E. Watanabe, R. Hiramatsu, K. Nakayama, K. I. Nakayama, and M. Kasuga
Skp2 Controls Adipocyte Proliferation during the Development of Obesity
J. Biol. Chem.,
January 19, 2007;
282(3):
2038 - 2046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Davicioni, F. Graf Finckenstein, V. Shahbazian, J. D. Buckley, T. J. Triche, and M. J. Anderson
Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar Rhabdomyosarcomas.
Cancer Res.,
July 15, 2006;
66(14):
6936 - 6946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Huang, K. M. Regan, F. Wang, D. Wang, D. I Smith, J. M. A. van Deursen, and D. J. Tindall
Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation
PNAS,
February 1, 2005;
102(5):
1649 - 1654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-W. Zhang, M. Kaneda, and I. Morita
The Gap Junction-independent Tumor-suppressing Effect of Connexin 43
J. Biol. Chem.,
November 7, 2003;
278(45):
44852 - 44856.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|